Taiwan FDA registration ad7d403d1844acb0ed14dbcd65414556
"Bidi" antibiotic test kit - isoniacinyl/rispenamycin
TW: "必帝" 抗生素試驗套組-異菸鹼醯/立汎黴素
Taiwan·Risk Class 2·BECTON, DICKINSON AND COMPANY (BD)·Registered Dec 29, 2005 – Dec 29, 2025ExpiredRegistration details
- Analysis ID
- ad7d403d1844acb0ed14dbcd65414556
- Customs Code
- DHA00601578705
Company information
- Manufacturer
- BECTON, DICKINSON AND COMPANY (BD)
- Manufacturer Country
- United States
- Authorized Representative
- BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE)
Product details
- Intended Use
- 用來檢測培養之Mycobacterium tuberculosis對isoniazid(INH), rifampin(RIF)的耐受性.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.1640 抗菌感受性試驗粉末
- Import Information
- import
Dates and status
- Registration Date
- Dec 29, 2005
- Expiry Date
- Dec 29, 2025
About this record
Access comprehensive regulatory information for "Bidi" antibiotic test kit - isoniacinyl/rispenamycin in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number ad7d403d1844acb0ed14dbcd65414556 and manufactured by BECTON, DICKINSON AND COMPANY (BD). The authorized representative in Taiwan is BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices